Advertisement
Screener

MiMedx Group, Inc. (MDXG) Current Portion of Long-Term Debt

2.8 / 5 stars · 68/120 Roast Me

MiMedx Group, Inc. Current Portion of Long-Term Debt

MiMedx Group, Inc. (MDXG) had Current Portion of Long-Term Debt of $1.50 million as of 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current

us-gaap:LongTermDebtCurrent · last filed 2026-07-29

  • 2026-06-30: Long-term Debt, Current Maturities $1.50M.
  • 2026-03-31: Long-term Debt, Current Maturities $1.50M.
  • 2025-12-31: Long-term Debt, Current Maturities $1.50M.
  • 2025-09-30: Long-term Debt, Current Maturities $1.38M.
Period endLong-term Debt, Current Maturities
2026-06-30$1.50M
10-Q · filed 2026-07-29
2026-03-31$1.50M
10-Q · filed 2026-04-29
2025-12-31$1.50M
10-Q · filed 2026-07-29
2025-09-30$1.38M
10-Q · filed 2025-10-29
2025-06-30$1.25M
10-Q · filed 2025-07-30
2025-03-31$1.13M
10-Q · filed 2025-04-30
2024-12-31$1.00M
10-K · filed 2026-02-25
2024-09-30$1.00M
10-Q · filed 2024-10-30
2024-06-30$1.00M
10-Q · filed 2024-07-31
2024-03-31$1.00M
10-Q · filed 2024-04-30
2023-12-31$1.00M
10-K · filed 2025-02-26
2020-12-31$0.00
10-K · filed 2021-03-08
2020-09-30$0.00
10-Q · filed 2020-11-04
2020-06-30$3.75M
10-Q · filed 2020-08-04
2020-03-31$3.75M
10-Q · filed 2020-07-06
2019-12-31$3.75M
10-K · filed 2021-03-08
2019-09-30$3.75M
10-Q · filed 2020-07-06
2019-06-30$3.75M
10-Q · filed 2020-07-06
2018-12-31$0.00
10-K · filed 2020-07-06
2012-12-31$0.00
10-K · filed 2013-03-15
2011-12-31$1.13M
10-K · filed 2013-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
SpyGlass Pharma, Inc. (SGP)United States$0.925B